WOOO Bucko. Hold your tongue. The National Enquirer was right about Elvis still being alive and living in France and now the facts have proven that John Kennedy was never assasinated by Oswald but actually moved to Cuba to be with his friend Castro.
The discussion about buy-outs is wishful thinking but what would be interesting is a management buy-out along with the folks who invested in the spring. They could probably buy the rest of the shareholders out for 6 or 7 dollars a share and hope that their investment that they paid 10 a share for last spring is really worth what they think..
You are so annoying. Get a life. Most people on this board are long term investors who know this company quite well. You really seem to have a problem that unfortunately is not the focus of Compugen's research.
Today's announced discovery appears to be a game changer and has profound implications if the rat model proves successful in humans. The value of this molecule alone could (should) be substantilly greater than the previous announced colaberation. which may speak to why it seems to have taken so long to get an agreement -- or perhaps we have been waiting for these results prior to colaberation in order to more accurately reflect future potential and value of the molecule. This now should get very interesting.Yet another proof of our amazing scientific capabilities at a time when big pharma is reducing R&D investments.
Interesting that Merck announced cutting 8,500 positions today with about half in R&D. The 8,500 will reduce costs by $2.5 billion. Compugen lists 50 employees and look what they have been able to accomplish at a cost of less than $20 million a year!